SI2638064T1 - Celični gojitveni medij in postopek za izražanje proteina, pri čemer medij in postopek obsegata inhibitor PAM - Google Patents

Celični gojitveni medij in postopek za izražanje proteina, pri čemer medij in postopek obsegata inhibitor PAM

Info

Publication number
SI2638064T1
SI2638064T1 SI201131994T SI201131994T SI2638064T1 SI 2638064 T1 SI2638064 T1 SI 2638064T1 SI 201131994 T SI201131994 T SI 201131994T SI 201131994 T SI201131994 T SI 201131994T SI 2638064 T1 SI2638064 T1 SI 2638064T1
Authority
SI
Slovenia
Prior art keywords
medium
cell culture
protein expression
culture medium
pam inhibitor
Prior art date
Application number
SI201131994T
Other languages
English (en)
Slovenian (sl)
Inventor
Corinna Sonderegger
Julia Schmutzhard
Christine Heel
Thomas Stangler
Original Assignee
Sandoz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Gmbh filed Critical Sandoz Gmbh
Publication of SI2638064T1 publication Critical patent/SI2638064T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0031Serum-free culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/005Protein-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/71Oxidoreductases (EC 1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI201131994T 2010-11-09 2011-11-09 Celični gojitveni medij in postopek za izražanje proteina, pri čemer medij in postopek obsegata inhibitor PAM SI2638064T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10190532A EP2450375A1 (fr) 2010-11-09 2010-11-09 Milieu de culture cellulaire et procédé pour l'expression de protéines, ledit milieu et ledit procédé comprenant un inhibiteur de PAM
PCT/EP2011/069756 WO2012062810A2 (fr) 2010-11-09 2011-11-09 Milieu de culture de cellules et procédé pour l'expression d'une protéine, lesdits milieu et procédé comprenant un inhibiteur de la pam
EP11782121.5A EP2638064B1 (fr) 2010-11-09 2011-11-09 Milieu de culture de cellules et procédé pour l'expression d'une protéine, lesdits milieu et procédé comprenant un inhibiteur de la pam

Publications (1)

Publication Number Publication Date
SI2638064T1 true SI2638064T1 (sl) 2021-11-30

Family

ID=43795181

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131994T SI2638064T1 (sl) 2010-11-09 2011-11-09 Celični gojitveni medij in postopek za izražanje proteina, pri čemer medij in postopek obsegata inhibitor PAM

Country Status (13)

Country Link
US (2) US9062337B2 (fr)
EP (2) EP2450375A1 (fr)
JP (2) JP6298295B2 (fr)
KR (2) KR101905204B1 (fr)
CN (2) CN103298830A (fr)
AU (1) AU2011328166B2 (fr)
CA (1) CA2816394A1 (fr)
DK (1) DK2638064T3 (fr)
HU (1) HUE055573T2 (fr)
PL (1) PL2638064T3 (fr)
SG (2) SG190182A1 (fr)
SI (1) SI2638064T1 (fr)
WO (1) WO2012062810A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
WO2008033517A2 (fr) 2006-09-13 2008-03-20 Abbott Laboratories Améliorations à la culture de cellules
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
EP2921501A1 (fr) 2008-10-20 2015-09-23 Abbvie Inc. Isolement et purification d'anticorps par chromatographie d'affinité de la protéine A
EP2450375A1 (fr) 2010-11-09 2012-05-09 Sandoz Gmbh Milieu de culture cellulaire et procédé pour l'expression de protéines, ledit milieu et ledit procédé comprenant un inhibiteur de PAM
EP2702077A2 (fr) 2011-04-27 2014-03-05 AbbVie Inc. Procédé de contrôle du profil de galactosylation de protéines exprimées de manière recombinante
CN104903447A (zh) * 2012-04-16 2015-09-09 力奇制药公司 在用于蛋白质表达的细胞系中减少酰胺化的氨基酸形成
WO2013158273A1 (fr) 2012-04-20 2013-10-24 Abbvie Inc. Procédés de modulation de la distribution de variant de lysine c-terminal
WO2013158279A1 (fr) 2012-04-20 2013-10-24 Abbvie Inc. Procédés de purification de protéines pour réduire des espèces acides
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (fr) 2012-05-24 2013-11-28 Abbvie Inc. Nouvelle purification d'anticorps au moyen de chromatographie à interaction hydrophobe
WO2014035475A1 (fr) 2012-09-02 2014-03-06 Abbvie Inc. Procédés de contrôle de l'hétérogénéité des protéines
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
AU2013381687A1 (en) 2013-03-12 2015-09-24 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (fr) 2013-03-14 2014-10-02 Abbvie Inc. Anticorps anti-tnfα ayant mutés et leurs procédés d'utilisation
WO2015024977A1 (fr) 2013-08-20 2015-02-26 Lek Pharmaceuticals D.D. Milieux de culture cellulaire et procédé pour réguler l'α-amidation et/ou le clivage d'acides aminés c-terminaux de polypeptides
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP3500586B1 (fr) 2016-10-17 2021-02-24 Enzene Biosciences Ltd. Procédé continu de réduction d'hétérogénéité de protéine thérapeutique
US20220177818A1 (en) 2019-04-01 2022-06-09 The Automation Partnership (Cambridge ) Ltd. Operation process for a cell cultivation system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000517188A (ja) * 1996-08-30 2000-12-26 ライフ テクノロジーズ,インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
US20080160577A1 (en) * 2005-02-04 2008-07-03 Glaxo Group Limited Optimization of Heterologous Polypeptide Expression
US20080227134A9 (en) * 2005-09-16 2008-09-18 Unigene Laboratories Inc. Glyoxylate assays and their use of inden tifying natural amidated compounds
BRPI0617491B1 (pt) * 2005-10-18 2021-04-27 Ajinomoto Co., Inc Processo para produção de ácido succínico
SG187038A1 (en) 2010-07-15 2013-02-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
EP2450375A1 (fr) 2010-11-09 2012-05-09 Sandoz Gmbh Milieu de culture cellulaire et procédé pour l'expression de protéines, ledit milieu et ledit procédé comprenant un inhibiteur de PAM

Also Published As

Publication number Publication date
JP2013541963A (ja) 2013-11-21
US20150267238A1 (en) 2015-09-24
DK2638064T3 (da) 2021-10-04
SG190182A1 (en) 2013-06-28
CN107629995A (zh) 2018-01-26
EP2638064B1 (fr) 2021-07-21
WO2012062810A3 (fr) 2012-07-05
CN103298830A (zh) 2013-09-11
EP2450375A1 (fr) 2012-05-09
WO2012062810A2 (fr) 2012-05-18
SG10201602507UA (en) 2016-05-30
US9062337B2 (en) 2015-06-23
JP2017035084A (ja) 2017-02-16
AU2011328166B2 (en) 2017-02-23
AU2011328166A1 (en) 2013-05-30
HUE055573T2 (hu) 2021-12-28
PL2638064T3 (pl) 2021-12-20
US20130337506A1 (en) 2013-12-19
KR20180082643A (ko) 2018-07-18
KR101991215B1 (ko) 2019-09-30
KR20130131355A (ko) 2013-12-03
KR101905204B1 (ko) 2018-10-05
EP2638064A2 (fr) 2013-09-18
CA2816394A1 (fr) 2012-05-18
JP6298295B2 (ja) 2018-03-20
US10106828B2 (en) 2018-10-23

Similar Documents

Publication Publication Date Title
SG10201602507UA (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
IL273159A (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
PL2393917T3 (pl) Podłoże do hodowli nabłonkowych komórek macierzystych i organoidów zawierających komórki macierzyste
IL226971B (en) Cell culture medium
EP2582788A4 (fr) Milieu de culture cellulaire à composition chimique définie, exempt de sérum
HK1171790A1 (zh) 用於 蛋白表達的細胞培養基
EP2644694A4 (fr) Procédé et milieu de culture pour améliorer l'efficacité d'induction de différenciation de cellules souches pluripotentes
GB2497059B (en) Culture medium, method for culturing listeria,and method for dtecting listeria
EP2554657A4 (fr) Procédé de séparation de cellules, milieu de culture cellulaire, et dispositif de séparation de cellules
GB2460552B (en) Stem cell culture media and methods
EP2843041A4 (fr) Milieu de culture pour cellules souches et procédé de culture de cellules souches l'utilisant
EP2491111A4 (fr) Produit de culture/manipulation de cellules et procédé pour la production et l'utilisation de celui-ci
HK1147218A1 (en) Stem cell lines, their application and culture methods
GB201113641D0 (en) Cell culture support and cell culture method
EP2480655B8 (fr) Milieu de culture de cellules
HUE050984T2 (hu) Tenyészközeg epiteliális õssejtekhez és az õssejteket tartalmazó organoidokhoz
AU2010901922A0 (en) Media and methods for cell culture
AU2009901852A0 (en) Media and methods for cell culture
PT3061808T (pt) Meio de cultura para células estaminais epiteliais e organóides compreeendendo as referidas células estaminais
GB0810304D0 (en) Stem cell culture media and methods
GB0821363D0 (en) Stem cell culture media and methods
GB201007863D0 (en) Bioreactor for cell culture